MediciNova Inc (MNOV) News Headlines

▮ More

Date

Headline

8/21/2018 3:16:53 AM AMRX Soars On Contract Win, TRPX Looks Ahead With Hope, ALXN To Face FDA In Feb

7/29/2018 8:49:42 PM MediciNova Announces Full Enrollment In ALS Biomarker Clinical Trial

7/10/2018 8:35:29 PM INSP Soars On Aetna Coverage, BTAI On Track, VTL Awaits Data In Sep.

7/10/2018 9:43:26 AM MediciNova Inc. (MNOV) Is Climbing On Study Results

5/8/2018 1:47:04 AM It's Raining FDA Approvals, MSON Muscling Up, RDHL To Report Data In Aug.

4/23/2018 6:02:38 AM Innovus Pharma Adds Ryan Selhorn As VP, CFO

4/13/2018 6:33:38 AM MediciNova Announces Presentation Of Positive Results From Interim Analysis Of Phase 2 Trial Of MN-001 (tipelukast)

4/7/2018 11:02:20 PM An Ear To The Pharma: 9 Stocks To Watch This Week (SELB, AGLE, BPMC, MNOV…)

4/2/2018 9:11:21 PM SLS Gets A Shot In The Arm, BLFS Full Of Life, MNOV Soars On NASH Trial Data

4/1/2018 9:35:05 PM MediciNova's Phase II NASH Trial To Be Stopped Early, Shows Positive Results

3/29/2018 6:32:10 AM MediciNova Reports Results Of Phase 2 Clinical Trial Of MN-166 (ibudilast) In Methamphetamine Dependence

3/28/2018 9:10:29 PM MediciNova, Univ. Of Sydney Concord Cancer Centre To Evaluate MN-166 In CIPN

3/28/2018 8:34:02 PM B. Riley FBR Starts MediciNova Inc (MNOV) At Buy With $22 Price Target

2/7/2018 10:57:03 PM CBMG Up 50% YTD, HAIR Keeps Falling, MNOV To Report NASH Trial Data In April

2/6/2018 7:21:32 PM ARRY's COLUMBUS Turns Heads, ZFGN On Course, MNOV UP 66% YTD

2/1/2018 10:11:34 PM AGN's Superbug Antibiotic Gets FDA Nod, AFMD Soars, Boxed Warning For Ocaliva

1/31/2018 7:11:32 AM MediciNova Announces Presentation Of SPRINT-MS Phase 2b Study Of MN-166 In Progressive MS At The ACTRIMS Forum

1/16/2018 12:57:37 AM The Race To Find A Treatment For NASH

Older Articles

Medicinova Inc (MNOV)